Back to DNLI

Denali Therapeutics Inc. 10-K

Accession 0001714899-23-000049

Filing information

CIK
0001714899
Report date
2022-12-31
Filing date
2023-02-27
Form
10-K
Primary document
dnli-20221231.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.